Back to Search
Start Over
Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: an update
- Source :
- FEMS Microbiology Letters, FEMS Microbiology Letters, Wiley-Blackwell, 2013, 344 (1), pp.1-9. ⟨10.1111/1574-6968.12159⟩, CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET
- Publication Year :
- 2013
- Publisher :
- HAL CCSD, 2013.
-
Abstract
- Lactic acid bacteria (LAB) represent a heterogeneous group of microorganisms naturally present in many foods and those have proved to be effective mucosal delivery vectors. Moreover, some specific strains of LAB exert beneficial properties (known as probiotic effect) on both human and animal health. Although probiotic effects are strain-specific traits, it is theoretically possible, using genetic engineering techniques, to design strains that can exert a variety of beneficial properties. During the two past decades, a large variety of therapeutic molecules has been successfully expressed in LAB, and although this field has been largely reviewed in recent years, approximately 20 new publications appear each year. Thus, the aim of this minireview is not to extensively assess the entire literature but to update progress made within the last 2 years regarding the use of the model LAB Lactococcus lactis and certain species of lactobacilli as live recombinant vectors for the development of new safe mucosal vaccine. Fil: Leblanc, Jean Guy Joseph. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Tucumán. Centro de Referencia Para Lactobacilos (i); Argentina; Universidad Nacional de Tucuman. Facultad de Medicina. Departamento de Investigacion. Catedra de Metodologia de la Invest.cientifica; Argentina; Fil: Aubry, Camille. Institut National de la Recherche Agronomique; Francia; Fil: Cortes-Perez, Naima G.. Institut National de la Recherche Agronomique; Francia; Fil: de Moreno, Maria Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Tucumán. Centro de Referencia Para Lactobacilos (i); Argentina; Fil: Vergnolle, Nathalie. INSERM; Francia; Centre National de la Recherche Scientifique; Francia; Universite Paul Sabatier; Francia; Fil: Langella, Philippe. Institut National de la Recherche Agronomique; Francia; Fil: Azevedo, Vasco. Universidade Federal Do Minas Gerais; Brasil; Fil: Chatel, Jean-Marc. Institut National de la Recherche Agronomique; Francia; Fil: Miyoshi, Anderson. Universidade Federal Do Minas Gerais; Brasil; Fil: Berúdez-Humarán, Luis G.. Institut National de la Recherche Agronomique; Francia
- Subjects :
- LACTOBACILLUS-CASEI
[SDV.SA]Life Sciences [q-bio]/Agricultural sciences
Lactococcus
law.invention
Probiotic
chemistry.chemical_compound
law
Lactobacillus
COMPLETE GENOME SEQUENCE
mucosal vaccines
0303 health sciences
Vaccines
biology
IMMUNE-RESPONSES
VACCINE DELIVERY
Therapeutic Molecules
3. Good health
Lactic acid
Genetically modified organism
therapeutic molecules
Cytokines
ORAL IMMUNIZATION
Lactobacillus casei
Otras Ingenierías y Tecnologías
Genetic Vectors
STREPTOCOCCUS-LACTIS
INGENIERÍAS Y TECNOLOGÍAS
Microbiology
03 medical and health sciences
GROWTH-FACTOR-I
Genetics
Lactic Acid Bactera
Animals
Humans
LACTOCOCCUS-LACTIS
Molecular Biology
BALB/C MICE
030304 developmental biology
purl.org/becyt/ford/2.11 [https]
Mucous Membrane
030306 microbiology
Probiotics
Lactococcus lactis
EXPRESSING INTERLEUKIN-10
biology.organism_classification
cytokines
lactic acid bacteria
chemistry
purl.org/becyt/ford/2 [https]
Mucosal Vaccines
Bacteria
Subjects
Details
- Language :
- English
- ISSN :
- 03781097 and 15746968
- Database :
- OpenAIRE
- Journal :
- FEMS Microbiology Letters, FEMS Microbiology Letters, Wiley-Blackwell, 2013, 344 (1), pp.1-9. ⟨10.1111/1574-6968.12159⟩, CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET
- Accession number :
- edsair.doi.dedup.....0f8214301c7e7823f0cadfb714cc02cf
- Full Text :
- https://doi.org/10.1111/1574-6968.12159⟩